In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| 10-K | 10-K | 10-K | 10-K |
Revenues: |
Medical office buildings | 54.3 | 18.4 | 1.3 | |
Seniors Housing Communities | 48.3 | 1.9 | | |
Senior living facilities | 22.7 | 15.5 | 2.1 | |
Total revenues [+] | 125.4 | 35.7 | 3.3 | 0.0 |
Tenant reimbursements | 11.1 | 5.2 | 0.8 | |
Lease / rental | 107.8 | 30.4 | 2.6 | |
Revenue growth [+] | 250.8% | 978.4% | | |
Medical office buildings | 195.6% | 1358.2% | | |
Seniors Housing Communities | 2437.6% | | | |
Senior living facilities | 47.0% | 653.0% | | |
Cost of goods sold | 46.7 | 6.6 | 0.9 | 0.0 |
Gross profit | 78.7 | 29.2 | 2.5 | 0.0 |
Gross margin | 62.8% | 81.6% | 74.0% | |
Selling, general and administrative [+] | 4.6 | 0.9 | 0.4 | |
General and administrative | 4.6 | 0.9 | 0.4 | 0.0 |
Other selling, general and administrative | | | | 0.0 |
Other operating expenses | | 1.0 | | |
EBITDA [+] | 74.1 | 27.3 | 2.0 | |
EBITDA growth | 171.5% | 1249.3% | -202300.0% | |
EBITDA margin | 59.1% | 76.3% | 61.0% | |
Depreciation | 42.5 | 15.1 | 1.2 | |
EBITA | 31.5 | 12.2 | 0.8 | 0.0 |
EBITA margin | 25.2% | 34.2% | 25.6% | |
Amortization of intangibles | 24.9 | 4.3 | 0.4 | |
EBIT [+] | 6.6 | 8.0 | 0.5 | 0.0 |
EBIT growth | -16.9% | 1534.9% | -48800.0% | |
EBIT margin | 5.3% | 22.3% | 14.7% | |
Non-recurring items | 13.6 | 9.4 | 3.4 | |
Interest expense, net [+] | 15.0 | 9.2 | 1.2 | |
Interest expense | 15.8 | 9.2 | 1.2 | |
Interest income | 0.9 | | | |
Other income (expense), net [+] | -0.2 | 0.0 | 0.0 | |
Other | -0.1 | 0.0 | 0.0 | |
Pre-tax income | -22.2 | -10.6 | -4.1 | 0.0 |
Income taxes | 0.1 | 0.0 | 0.0 | 0.0 |
Tax rate | | 0.0% | 0.8% | 0.0% |
Minority interest | -0.1 | 0.0 | 0.0 | |
Net income | -22.1 | -10.6 | -4.1 | 0.0 |
Net margin | -17.6% | -29.8% | -125.2% | |
|
Basic EPS [+] | ($0.15) | ($0.43) | ($2.52) | $0.00 |
Growth | -65.7% | -83.1% | 5030061.0% | |
Diluted EPS [+] | ($0.15) | ($0.43) | ($2.52) | $0.00 |
Growth | -65.7% | -83.1% | 5030061.0% | |
|
Dividends per share [+] | $0.30 | $0.32 | $0.23 | |
Growth | -6.2% | 38.8% | | |
|
Shares outstanding (basic) [+] | 151.7 | 25.0 | 1.6 | 20.0 |
Growth | 506.5% | 1416.0% | -91.8% | |
Shares outstanding (diluted) [+] | 151.7 | 25.0 | 1.6 | 20.0 |
Growth | 506.5% | 1416.0% | -91.8% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |